The approval of clinical research by an independent ethics committee -a compulsory requirement and not a matter of the investigator's choosing
For four decades, a requirement for investigators aiming to conduct clinical research that involve human subjects has been to submit their research protocol to an independent ethics committee (EC) for ethical considerations prior to commencing the study participant recruitment. It has been argued that it must be the editors of scientific journals that should be responsible for assuring that adherence to ethical standards is being followed. In fact, WMA has declared bluntly in article 36 of the current version that "Reports of research not in accordance with the principles of this Declaration should not be accepted for publication" (WAME). Their respective guidance documents opens for publication even in lack of an IRB/EC, i.e. "…if no formal ethics committee is available, a statement indicating that the research was conducted according to the principles of the Declaration of Helsinki should be included", 16 alternatively stated "For those investigators who do not have access to formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed". 17 There is no guidance as to how an editor should proceed to authenticate any claim of inaccessibility to a formal IRB/EC. The Committee on Publication Ethics (COPE) is somewhat more explicit on the need for an independent ethical approval, citing cases on their website where the lack of approval in a submitted manuscript should raise concerns of proper ethical conduct of clinical studies. 18 It is likely that the discrepancies of opinion amongst the voluntary medical editor organizations for the need for a formal statement in the materials and methods section about ethics committee approval is reflected in instructions to authors, e.g., within
the fields of oral-cranio-maxillofacial-facial plastic surgery. 19 On the other hand, an argument can be made that once an editor has received a manuscript, the unethical clinical research has already been conducted and completed. True, a problem getting their research paper published may be a deterrent for the investigator-author, but it is hardly a comfort for the study participant recruited into an unethical clinical study. Moreover, publishing is today facilitated by a burgeoning predatory publishing industry that welcome anything from anyone without much peer-review scrutiny, 20 and it seems like nobody are able to stop the activity. Perhaps in the future, the main criteria for differentiating between a predatory and a scholarly publication is whether there is a statement in the M&M about an IRB/EC.
For this journal, we hope that the section in the instructions to authors titled "Protection of human subjects and animals in research" is unambiguous. 21 We believe that it is appropriate and in the best interest of all stakeholders that a statement must be included in the Methods section of all submitted manuscript indicating that the protocol and procedures employed were reviewed and approved by the appropriate IRB/EC. 
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